Home/Filings/4/0001773383-24-000227
4//SEC Filing

Dollentz-Scharer Matthias 4

Accession 0001773383-24-000227

CIK 0001773383other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:18 PM ET

Size

14.1 KB

Accession

0001773383-24-000227

Insider Transaction Report

Form 4
Period: 2024-11-25
Dollentz-Scharer Matthias
EVP, Chief Customer Officer
Transactions
  • Sale

    Common Stock

    2024-11-25$55.35/sh45,987$2,545,201100,387 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-256,9370 total
    Exercise: $16.00Exp: 2029-07-31Common Stock (6,937 underlying)
  • Exercise/Conversion

    Common Stock

    2024-11-25$16.00/sh+6,937$110,992107,324 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-2539,0500 total
    Exercise: $33.03Exp: 2030-05-15Common Stock (39,050 underlying)
  • Sale

    Common Stock

    2024-11-25$55.22/sh20,000$1,104,388100,387 total
  • Exercise/Conversion

    Common Stock

    2024-11-25$33.03/sh+39,050$1,289,822146,374 total
Footnotes (4)
  • [F1]The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.20 to $55.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F2]The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.32 to $55.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]Stock Options granted on July 31, 2019, 25% vested and became exercisable on August 15, 2020, and the remainder vested in 12 equal quarterly installments thereafter.
  • [F4]Stock Options granted on May 15, 2020, 25% vested and become exercisable on May 15, 2021, and the remainder vested in 12 equal quarterly installments.

Issuer

Dynatrace, Inc.

CIK 0001773383

Entity typeother

Related Parties

1
  • filerCIK 0001945404

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:18 PM ET
Size
14.1 KB